Our study reveals a new regulation mechanism of LSH and the effectively suppressive impact of degrasyn on HCC progression, indicating that USP5 might be further developed into a potential therapeutic target in HCC (Figure 7F). The gene discussed is HELLS; the disease is hepatocellular carcinoma.